Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARTIVION, INC. Director's Dealing 2020

Dec 16, 2020

31684_dirs_2020-12-16_da8513ac-a7ca-4960-8c1b-b0faf7f9c8b8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2020-12-15

Reporting Person: Capps Scott B (VP, Clinical Research)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Common Stock M 10000 $9.97 Acquired 157006 Direct
2020-12-15 Common Stock S 8366 $21.3427 Disposed 148640 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-15 Stock Option (Right to Buy) $9.97 M 10000 Disposed 2021-02-26 Common Stock (10000) Direct

Footnotes

F1: Reflects weighted average price. Range was from $21.25 to $21.45. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/26/2015